NCT02432261View on ClinicalTrials.gov

Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Healthy
Interventions
DRUG

Nestorone® /testosterone gel

Nestorone® /testosterone combined gel

DRUG

Testosterone only gel

Testosterone only gel

Trial Locations (2)

90502

LA Biomedical Research Institute, Torrance

98195

University of Washington, Seattle

Sponsors

Lead Sponsor

Kimberly Myer
All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Kimberly Myer

OTHER